Emergent Health Valuation

EMGE Stock  USD 0  0.00  0.00%   
Emergent Health seems to be fairly valued based on Macroaxis valuation methodology. Our model computes the value of Emergent Health Corp from reviewing the firm fundamentals such as Shares Outstanding of 41.93 M, current valuation of 1.65 M, and Profit Margin of (2.42) % as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
0
Please note that Emergent Health's price fluctuation is out of control at this time. Calculation of the real value of Emergent Health Corp is based on 3 months time horizon. Increasing Emergent Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Emergent pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Emergent Health Corp. Since Emergent Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Emergent Pink Sheet. However, Emergent Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.001 Real  9.78E-4 Hype  0.001155 Naive  0.001019
The real value of Emergent Pink Sheet, also known as its intrinsic value, is the underlying worth of Emergent Health Corp Company, which is reflected in its stock price. It is based on Emergent Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Emergent Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.001
Real Value
7.71
Upside
Estimating the potential upside or downside of Emergent Health Corp helps investors to forecast how Emergent pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Emergent Health more accurately as focusing exclusively on Emergent Health's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.0007.71
Details
Naive
Forecast
LowNext ValueHigh
0.0000207.71
Details

Emergent Health Total Value Analysis

Emergent Health Corp is currently forecasted to have valuation of 1.65 M with market capitalization of 222.23 K, debt of 0, and cash on hands of 496.69 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Emergent Health fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
1.65 M
222.23 K
0
496.69 K

Emergent Health Investor Information

The company recorded a loss per share of 0.01. Emergent Health Corp had not issued any dividends in recent years. The entity had 10:11 split on the 31st of December 2009. Emergent Health Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.

Emergent Health Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Emergent Health has an asset utilization ratio of 95.87 percent. This indicates that the Company is making $0.96 for each dollar of assets. An increasing asset utilization means that Emergent Health Corp is more efficient with each dollar of assets it utilizes for everyday operations.

Emergent Health Profitability Analysis

The company reported the previous year's revenue of 989.84 K. Net Income was 121.03 K with profit before overhead, payroll, taxes, and interest of 79.48 K.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Emergent Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Emergent Health and how it compares across the competition.

About Emergent Health Valuation

The pink sheet valuation mechanism determines Emergent Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of Emergent Health. We calculate exposure to Emergent Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Emergent Health's related companies.
Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. As of August 26, 2014, Emergent Health Corp was taken private. EMERGENT HEALTH operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 6 people.

8 Steps to conduct Emergent Health's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Emergent Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Emergent Health's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Emergent Health's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Emergent Health's revenue streams: Identify Emergent Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Emergent Health's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Emergent Health's growth potential: Evaluate Emergent Health's management, business model, and growth potential.
  • Determine Emergent Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Emergent Health's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Emergent Health Growth Indicators

Investing in growth stocks can be very risky. If the company such as Emergent Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Retained Earnings471.3 K

Complementary Tools for Emergent Pink Sheet analysis

When running Emergent Health's price analysis, check to measure Emergent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Health is operating at the current time. Most of Emergent Health's value examination focuses on studying past and present price action to predict the probability of Emergent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Health's price. Additionally, you may evaluate how the addition of Emergent Health to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios